Answers are grounded in this paper and cite their sources.
Opportunistic fungal pathogens, including Candida , Aspergillus , and Cryptococcus species, employ metabolic and organellar adaptations to survive host stresses and antifungal treatments. Cryptococcus neoformans thrives in a nutrient-limiting environment and undergoes prolonged replicative stress during chronic infection. Nutrient limitation is modeled as calorie restriction (CR), while replicative stress is manifested through replicative aging (RA). C. neoformans adapts to these stresses and undergoes many physiological changes. These changes include increased azole tolerance and higher drug efflux pump activities during CR and RA, which correlate with altered mitochondrial structures and functions. Mitochondrial pathways behave differently under RA and CR stress. For example, mitochondrial mass is significantly higher in aging cells, while it is significantly lower in CR-adapted cells. The role of mitochondria in antifungal tolerance in both RA and CR cells remains poorly understood. Multiple mitochondrial pathways contribute to antifungal tolerance. These include regulation of respiration, mitochondrial genome and protein functions, and calcium and iron homeostasis. Several inhibitors have been identified to target these mitochondrial pathways. The effects of these inhibitors on lowering antifungal tolerance in CR and RA-adapted cells need to be studied. This will aid in next-generation drug designing to combat the growing frequency of antifungal tolerance, especially in C. neoformans .
No takes yet. Share an insight, caveat, or question.
Bhattacharya et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: